133 related articles for article (PubMed ID: 10484869)
1. [An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology].
Cosentino A; Ghidoni D; Salemi M; Folicaldi S; Amadori A; Zani J; Grasso G; Bondi A
Pathologica; 1999 Apr; 91(2):101-6. PubMed ID: 10484869
[TBL] [Abstract][Full Text] [Related]
2. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
[TBL] [Abstract][Full Text] [Related]
3. New paradigm for ASCUS diagnosis using neural networks.
Kok MR; Habers MA; Schreiner-Kok PG; Boon ME
Diagn Cytopathol; 1998 Nov; 19(5):361-6. PubMed ID: 9812231
[TBL] [Abstract][Full Text] [Related]
4. Detection of unsuspected abnormalities by PAPNET-assisted review.
Mitchell H; Medley G
Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
[TBL] [Abstract][Full Text] [Related]
5. PAPNET testing for HSILs. The few cell/small cell challenge.
Solomon HM; Frist S
Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
[TBL] [Abstract][Full Text] [Related]
6. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
[TBL] [Abstract][Full Text] [Related]
8. Accuracy comparison between PAPNET diagnoses and conventional diagnoses in an Italian cervical cytology laboratory.
Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
Diagn Cytopathol; 1998 Oct; 19(4):279-83. PubMed ID: 9784992
[TBL] [Abstract][Full Text] [Related]
9. Rescreen effect in conventional and PAPNET screening: observed in a study using material enriched with positive smears.
van Ballegooijen M; Beck S; Boon ME; Boer R; Habbema JD
Acta Cytol; 1998; 42(5):1133-8. PubMed ID: 9755670
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
Fabbris E; Bucchi L; Folicaldi S; Amadori A; Ghidoni D; Medri M; Bondi A
Pathologica; 1998 Apr; 90(2):127-32. PubMed ID: 9619055
[TBL] [Abstract][Full Text] [Related]
11. PAPNET-directed rescreening of cervicovaginal smears: a study of 101 cases of atypical squamous cells of undetermined significance.
Ryan MR; Stastny JF; Remmers R; Pedigo MA; Cahill LA; Frable WJ
Am J Clin Pathol; 1996 Jun; 105(6):711-8. PubMed ID: 8659445
[TBL] [Abstract][Full Text] [Related]
12. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
Mango LJ; Valente PT
Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
[TBL] [Abstract][Full Text] [Related]
13. Costs and outcomes of PAPNET secondary screening technology for cervical cytologic evaluation. A community hospital's experience.
Brotzman GL; Kretzchmar S; Ferguson D; Gottlieb M; Stowe C
Arch Fam Med; 1999; 8(1):52-5. PubMed ID: 9932072
[TBL] [Abstract][Full Text] [Related]
14. Potentially difficult smears of women with squamous cell carcinoma pose fewer problems when PAPNET is used for primary screening.
Kok MR; Schreiner-Kok PG; Van Der Veen G; Boon ME
Cytopathology; 1999 Oct; 10(5):324-34. PubMed ID: 10588351
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the PAPNET system in a general pathology service.
Farnsworth A; Chambers FM; Goldschmidt CS
Med J Aust; 1996 Oct; 165(8):429-31. PubMed ID: 8913244
[TBL] [Abstract][Full Text] [Related]
16. Consistency of a double PAPNET scan of cervical smears.
Jenny J; Isenegger I; Boon ME; Husain OA
Acta Cytol; 1997; 41(1):82-7. PubMed ID: 9022731
[TBL] [Abstract][Full Text] [Related]
17. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
18. The PAPNET system for quality control of cervical smears: validation and limits.
Cenci M; Nagar C; Giovagnoli MR; Vecchione A
Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
[TBL] [Abstract][Full Text] [Related]
19. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of PAPNET testing as an ancillary tool to clarify the status of the "atypical" cervical smear.
Sherman ME; Schiffman MH; Mango LJ; Kelly D; Acosta D; Cason Z; Elgert P; Zaleski S; Scott DR; Kurman RJ; Stoler M; Lorincz AT
Mod Pathol; 1997 Jun; 10(6):564-71. PubMed ID: 9195573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]